The Pathology Laboratory Core of the Children's Hospital of Philadelphia is a core facility that provides a full range of services for morphologically based studies, ranging from routine histology to complex image analysis, aser capture microdissection, and tissue microarray preparation and analysis. Services include preparation of animal and human tissues for microscopic analysis including paraffin embedding and sectioning, and cryosectioning. The Core also provides services for detection of transgenes and transgene products including in situ hybridization and immunohistochemistry. This Core is directed by a board-certified anatomic pathologist, Dr. Alex Judkins, with additional pathologists on staff, providing optimal expertise for interpretation of results, troubleshooting of procedures, and development of new assays. (This facility is also staffed by clinically trained histotechnologists, with expertise in tissue processing, including frozen sections, histochemistry, and immunohistochemistry). This Core has a track record of productive interaction with the investigators of Projects 1, 2, and 4, and for the proposed PEGT will also provide services for Projects 3 and 5. The Cores najor assets include state-of-the-art equipment (laser capture microdissection), innovative techniques (tissue microarray), and an interactive and knowledgeable staff with considerable experience and expertise in characterizing new antibodies for immunohistochemistry. The Core is structured so that core personnel can provide services on a fee-for-service basis, or if they prefer, investigators can use the core's facilities to perform the studies themselves with training, advice and assistance provided as needed by the core staff. Because of the organizational structure already in place, this core is well qualified to serve as a shared resource for all the PEGT's and for other NHLBI-funded investigators.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
2U01HL066948-06
Application #
7155010
Study Section
Special Emphasis Panel (ZHL1-CSR-I (M1))
Project Start
2005-09-29
Project End
2006-08-31
Budget Start
2005-09-29
Budget End
2007-08-31
Support Year
6
Fiscal Year
2005
Total Cost
$138,899
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Margaritis, Paris (2010) Long-term expression of canine FVIIa in hemophilic dogs. Thromb Res 125 Suppl 1:S60-2
Margaritis, Paris; Roy, Elise; Aljamali, Majed N et al. (2009) Successful treatment of canine hemophilia by continuous expression of canine FVIIa. Blood 113:3682-9
Bedi, Maninder S; Alvarez Jr, Rene J; Kubota, Toru et al. (2008) Myocardial Fas and cytokine expression in end-stage heart failure: impact of LVAD support. Clin Transl Sci 1:245-8
Aljamali, Majed N; Margaritis, Paris; Schlachterman, Alexander et al. (2008) Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality. J Clin Invest 118:1825-34
Akache, Bassel; Grimm, Dirk; Shen, Xuan et al. (2007) A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8. Mol Ther 15:330-9
Chen, Jian; Wu, Qi; Yang, Pingar et al. (2006) Determination of specific CD4 and CD8 T cell epitopes after AAV2- and AAV8-hF.IX gene therapy. Mol Ther 13:260-9
Bedi, Maninder; McNamara, Dennis; London, Barry et al. (2006) Genetic susceptibility to atrial fibrillation in patients with congestive heart failure. Heart Rhythm 3:808-12
Grimm, Dirk; Pandey, Kusum; Nakai, Hiroyuki et al. (2006) Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype. J Virol 80:426-39
Inagaki, Katsuya; Fuess, Sally; Storm, Theresa A et al. (2006) Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol Ther 14:45-53
Manno, Catherine S; Arruda, Valder R; Pierce, Glenn F et al. (2006) Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12:342-7

Showing the most recent 10 out of 36 publications